Elan deal positions J&J ahead of Obamacare
July 02, 2009 at 13:11 PM EDT
With members of the baby-boom generation hitting retirement age in force in the next few years, drug companies are trying to line up the blockbuster medications that, they hope, will ease their suffering while also soothing investorsâ nerves. Witness Johnson & Johnson agreeing to buy an equity stake in Irish drugmaker Elan.